SCHEMBL12132129

SCHEMBL12132129

C=C1CN(C(C)(C)C)CCS1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13199319 0.74 — —
SCHEMBL10329936 0.63 — —
SCHEMBL278444 0.63 ALDH1A1 (0.33) —
SCHEMBL9975661 0.63 GRIN2D (0.32) —
SCHEMBL15688340 0.62 — —
SCHEMBL681245 0.62 — —
SCHEMBL16130222 0.62 CYP2B6 (0.32) —
SCHEMBL681107 0.61 GRIN2D (0.33) —
SCHEMBL15483615 0.61 ALDH1A1 (0.32) —
SCHEMBL21422563 0.59 GRIN2D (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063077-B2 Factor Xa inhibitors MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-11-22 — — US disclosed
US-20100249117-A1 FACTOR XA INHIBITORS MILLENNIUM PHARMACEUTICALS, INC. 2010-09-30 — — US disclosed
US-7763608-B2 Factor Xa inhibitors MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-07-27 — — US disclosed
US-20090030045-A1 FACTOR XA INHIBITORS MILLENNIUM PHARMACEUTICALS, INC. 2009-01-29 — — US disclosed
US-20070259924-A1 FACTOR XA INHIBITORS MILLENNIUM PHARMACEUTICALS, INC. 2007-11-08 — — US disclosed
Send feedback